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Abstract
The survival rate of 19 patients who underwent living-related kidney transplantation after
donor-specific blood transfusions (DST) was compared with that of 32 historical controls receiving
transplants without DST. The graft survival rate of the DST group was 82% after two and three
years. The graft survival rate of the DST group was significantly better than the 53% rate after
two years obtained with the 32 historical controls (p less than 0.05). We tested sera from 16 DST-
treated recipients to study the beneficial effect of DST on kidney allograft survival using the mixed
lymphocyte culture (MLC) serum inhibition test. The results demonstrated that MLC inhibitory
factors were induced in the serum of the recipient after completion of DST. This inhibition of MLC
was observed by treatment of responder lymphocytes with serum obtained three weeks after DST
plus rabbit complement. The inhibitory effect was also specific for responder cells in anti-donor
MLC. Regarding the correlation with rejection episodes, these MLC inhibitory factors were often
observed in the non-rejection group (p less than 0.05). The data suggest that such factors may be
anti-idiotypic antibodies and be associated with prolonged graft survival.
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